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We and others have introduced the use of the lac operator-repressor system as a method for providing
inducible gene expression for gene transfer experiments in animal cells (M. C.-T. Hu, and N. Davidson, Cell
48:555-566, 1987; J. Figge, C. Wright, C. J. Collins, T. M. Roberts, and D. M. Livingston, Cell 52:713-722,
1988). To improve the dynamic range of such an inducible system, we have investigated the effects of combining
the relief by isopropyl-4-D-thiogalactoside (IPTG) of negative control by the lac system with positive induction
by the natural inducers glucocorticoids and cadmium ion for a system based on the human metallothionein-HA
gene promoter. We used the chloramphenicol acetyltransferase gene as a reporter gene and inserted a lacO
sequence into the promoter between the GC box and metal-responsive element 1, between metal-responsive
element 1 and the TATA box, or between the TATA box and the transcription start site. Surprisingly, all of
these insertions had a significant inhibitory effect on promoter activity even in the absence of repressor.
However, with these lacO-containing constructs, the levels of gene expression after induction by glucocorticoid,
Cd2+, or both were considerably reduced in cells engineered to express the lac repressor. Derepression by
IPTG, coupled with induction by both dexamethasone and Cd2+ ion, then provided a high level of induced
expression, i.e., by a factor of approximately 100 over the basal level of expression. However, inserting the lacO
sequence well upstream just before the glucocorticoid-responsive element had much smaller effects on
expression levels in both repressor-negative and repressor-positive cells. This study describes a new, high-level-
inducible promoter system for gene transfer experiments. The observed effects are discussed in terms of current
models of the mechanisms by which transcription factors control gene expression.
Inducible promoter systems are very useful for controlling
the levels of gene expression of transfected genes for basic
studies of the cell biological effects of a given gene product
and, in some cases, for practical genetic engineering appli-
cations. We and others have previously described the use, in
mammalian cells, of the lac operator-repressor system for
this purpose (6, 9, 11, 15, 16, 25). It was shown that insertion
of the lac operator (lacO) into an otherwise constitutive
eucaryotic promoter provided lacI-dependent expression
when the genes were transfected into eucaryotic cells.
Furthermore, treatment of the lacI+ cells with isopropyl-,-
D-thiogalactoside (IPTG) resulted in significant derepres-
sion. Thus, the lac operator-repressor system was shown to
be potentially useful for the design of inducible gene expres-
sion systems for transfected genes. This system may be
particularly attractive for use with eucaryotic cells and
organisms because the inducer, IPTG, does not occur in
tissue culture media or in body fluids.
However, the levels of induction by IPTG observed by us
for a chimeric Moloney sarcoma virus simian virus 40 (SV40)
enhancer-promoter combination were at best 10:1 to 20:1
(15). The study presented here describes an effort to achieve
higher levels of inducibility in combination with a high level
of gene expression in the induced state. We reasoned that if
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one could insert the lacO sequence into an inducible eucary-
otic promoter in such a way that the positive induction by
the cognate inducer and the relief by IPTFG of repression by
the lac repressor were independent events, the overall
induction ratio should be multiplicative.
We chose the promoter of the human metallothionein "A
(hMT-IIA) gene. This gene is actively expressed in most cell
types, and its transcription is regulated in response to a
variety of environmental stimuli, including heavy-metal
ions, steroid and polypeptide hormones, growth factors,
cytokines, and phorbol ester tumor promoters (12, 18, 20,
21). These effects are mediated by specific regulatory pro-
teins that interact with distinct cis-acting elements in the
5'-flanking region of the gene (1, 21, 23, 24). In addition to
containing one glucocorticoid-responsive element (GRE)
and four metal ion responsive elements (MREs), the 5'-
flanking region contains four elements known to be involved
in controlling the basal level of expression: a TATA box, a
GC box, and two basal-level enhancer elements (BLEs) (18).
In the induced state, this promoter can provide levels of
expression higher than those from, for example, a dexameth-
asone-induced mouse mammary tumor virus promoter (17).
In this study, we used a 30-nucleotide synthetic, fully
symmetric lacO operator segment that has been shown to
bind repressor more strongly than does the native lacO
sequence (34) used in our earlier studies (15). We had
observed previously that the wild-type lac repressor ex-
pressed in animal cells was distributed in a 9:1 ratio between
cytoplasm and nucleus (15). To increase the concentration of
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repressor in the nucleus, we have recently designed a
modified protein with the minimal SV40 T-antigen karyo-
philic sequence fused to the carboxy terminus of the lac
repressor; we have observed that this modified repressor
binds correctly to the lacO sequence and is localized entirely
in the nucleus (M. C.-T. Hu and N. Davidson, Gene, in
press). We carried out the study described here in separate
cell lines expressing either the wild-type or the modified
repressor.
We found that a significant level of control of gene
expression could be achieved by lac repressor binding to an
inserted lacO segment and by derepression by IPTG. The
negative effects of lac repressor binding on chloramphenicol
acetyltransferase (CAT) expression were found to depend on
the position of the lacO insert relative to the sites of binding
of some of the endogenous positive regulatory proteins. The
implications of these results with respect to the mechanisms
by which transcription factors regulate gene expression are
discussed.
MATERIALS AND METHODS
Site-directed mutagenesis of the hMT-IIA promoter. A
-286 5' deletion mutant of the hMT-IIA promoter (21) linked
to the herpes simplex virus tk gene was kindly provided by
Michael Karin (University of California, San Diego). This
plasmid containing the hMT-IIA promoter was cleaved by
restriction endonuclease NcoI, and the ends of this NcoI site
were repaired with Escherichia coli DNA polymerase I large
fragment (Klenow) in the presence of four deoxynucleotide
triphosphates. The promoter DNA fragment was excised by
restriction endonuclease HindIlI, gel isolated, and sub-
cloned into the Hindlll and HincII sites of the vector
M13mpl9 (40) to give hMT-IIA/M13mpl9. The synthetic
oligonucleotide 5'-CGCCTCGGCATGCAAGGGGCT-3' (21-
mer) was used as a mutagenic primer to introduce three
nucleotide mutations at a region between the GRE and
BLE2 of the hMT-IIA promoter (Fig. 1A). The 5'-phosphor-
ylated mutagenic primer and an M13-specific primer, 5'-AT
GCCCCCTGCCTATTTCGG-3' (corresponding to nucleo-
tides 2054 to 2073 of M13mpl9), were simultaneously an-
nealed to a single-stranded DNA template of hMT-IIA/
M13mpl9, extended with Klenow enzyme, and ligated
essentially as described previously (41). Following transfor-
mation into bacterial strain MC1061.2, the mutant clones
were screened by dot blot analysis, using the 32P-labeled
mutagenic primer as a probe. Double-stranded (replicative-
form) DNA of the mutant clones was isolated and purified
from plaque-purified phages, and the newly engineered SphI
site was confirmed by restriction endonuclease digestion. In
addition, the mutated nucleotides within the hMT-IIA pro-
moter were confirmed by dideoxy-chain termination se-
quencing (2) of the phage-derived, single-stranded DNA. In
the same manner, the oligonucleotide 5'-ACGAGTGCGC
ATGCCCCGCC-3' (20-mer) was used as a mutagenic primer
to mutate three nucleotides at a region between the GC box
and MRE1 (Fig. 1A). Thus, a unique SphI site was created in
this region. Similarly, the oligonucleotide 5'-GAGTGCAG
TACTGCAAGCAGTGTTTATAGCTCGAGAGAGCCGG-3'
was used as a mutagenic primer to introduce simultaneously
two nucleotide mutations at a region between MRE1 and the
TATA box and three nucleotide mutations between the
TATA box and the transcription start site (Fig. 1A). In this
mutant clone, a unique XhoI site was generated between
MRE1 and the TATA box, and a unique ScaI site was
generated between the TATA box and the transcription start
site. Subsequently, all of the mutant hMT-IIA promoters
were excised from the mutant M13 clones by digestion with
restriction endonucleases Hindlll and BamHI. These 370-bp
HindIII-BamHI fragments were gel isolated and subcloned
into the pUCPLCAT vector (4), which does not contain a
eucaryotic promoter for CAT gene expression in eucaryotic
cells. This vector was digested with restriction endonu-
cleases HindIlI and BglII. The 4.4-kb HindIII-BglII frag-
ment was isolated and ligated with the several 370-bp Hin-
dIII-BamHI promoter fragments with T4 DNA ligase. The
vector also carried an SV40 small intron and a poly(A)
addition signal for the expression of CAT protein in mam-
malian cells. Thus, the resulting vectors all contain an
hMT-IIA promoter with point mutations to create unique
restriction sites in an otherwise conventional CAT gene
reporter construct.
Construction of the hMTCAT expression vectors containing
lacO sequence inserts. The oligonucleotide 5'-TGTGGAATT
GTGAGCGCTCACAATTCCACA-3' (30-mer), containing a
symmetric lacO sequence (34), was self-annealed to form a
blunt-ended double-stranded DNA segment. The latter was
inserted by blunt-end ligation into each of the unique restric-
tion sites created within the hMT-IIA promoter as described
above, using standard methods and where necessary filling
in restriction sites by repair with T4 DNA polymerase in the
presence of nucleotides.
We also prepared several hMT-IIA promoter elements
containing the 30-nucleotide lacO sequence flanked by what
we hoped were innocuous spacer sequences of moderate
length. This was accomplished by inserting the lacO se-
quence into the BamHI site of pBR322, excising a 420-bp
DNA fragment containing the lacO sequence at its center by
digestion with EcoRV, and adding a synthetic SphI linker.
Thus, the resulting DNA fragment contained the 30-bp lacO
sequence at the center with two flanking 190-bp DNA
segments as spacers, one on each side. This segment was
inserted at the unique SphI site at the -55 position of the
mutant hMT-IIA promoter or at the similar site at -226.
Cell culture and DNA transfections. The cell lines used
were Rat XC (American Type Culture Collection; ATCC
CCL 165) and two derivatives, XC35-5 and XC36-2, pre-
pared by us (Hu and Davidson, in press). XC35-5 cells had
been stably transfected with DNA expressing the wild-type
lacI gene. These cells expressed 2.2 x 105 functional mole-
cules per cell, of which 2 x 104 were localized in the cell
nucleus. XC36-2 cells had been transfected with a similar
construction expressing a modified lac repressor with the
SV40 T-antigen nuclear localization signal (NLS) fused to its
carboxy terminus. These cells expressed 5 x 103 functional
repressors, all of which were localized in the cell nucleus.
Cells were grown in plastic plates (Falcon) in Dulbecco
modified Eagle medium (DME; GIBCO) supplemented with
10% fetal calf serum (FCS; GIBCO), penicillin (100 U/ml),
and streptomycin (100 ,xg/ml). The antibiotic G418 (GIBCO)
was added to the medium at a final concentration of 400
,ug/ml as needed. Cells were cultivated at 37°C in a humidi-
fied atmosphere containing 5% CO2. For induction experi-
ments, IPTG (Bethesda Research Laboratories) was pre-
pared as a 1 M stock solution in sterile distilled H20;
dexamethasone (DEX; Sigma Chemical Co.) and CdCl2
(Sigma) were prepared as 1 and 5 mM stock solutions,
respectively, in phosphate-buffered saline (140 mM NaCl, 10
mM sodium phosphate, pH 7.4). For transient transfection,
cells were plated on the day before transfection at a density
of ca. 106 cells per 60-mm-diameter plastic plate (Falcon).
DEAE-dextran transfections (26, 38) were performed by
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FIG. 1. Structures of chimeric hMT-IIA promoters carrying the lacO sequence. (A) Sequence of the hMT-IIA promoter region from
position +1 (the major start site of transcription) to position -286 as described by Karin et al. (19). Upstream and proximal promoter
elements, including the GRE, the MREs, the GC box, the BLEs, and a TATA box, are indicated. The mutated nucleotides are shown above
the wild-type nucleotides ( T ), and the resulting new restriction endonuclease sites are designated. (B) Schematic representation of the various
hMTlacO-CAT constructs. The organization of the hMT-IIA promoter (23) is shown below the diagram of the plasmid vector pUCCAT (4),
which contains CAT-coding sequences, the SV40 small-t intron, and early poly(A) addition signal. The coding region of the CAT gene was
linked to the various chimeric hMT-IIA promoters. Positions of the lacO insertion are indicated A, and the position numbers are in
parentheses. , Spacer DNA segment (190 bp) flanking the lacO sequence.
washing the cells twice with 5 ml ofDME without serum and
then adding DEAE-dextran (500 pLg/ml; molecular weight,
500,000; Pharmacia) in 2 ml of DME with the appropriate
DNA (at 2 ,ug/ml) in the presence of chloroquine (2 ,ug/ml).
After 4 h of incubation at 37°C, the cells were shocked with
dimethyl sulfoxide in buffer containing 137 mM NaCl, 5 mM
KCl, 0.7 mM Na2HPO4, 6 mM dextrose, and 21 mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)
(pH 7.1) for 2 min at room temperature as described previ-
ously (26). After removal of the shock buffer, the cells were
washed once with 2 ml of phosphate-buffered saline and then
incubated in 5 ml of DME containing 10% FCS in a 5% CO2
B
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37°C incubator. After 12 h of incubation, the media were
replaced with fresh media with or without inducers, and cells
were incubated for 48 h before harvesting. For induction
experiments, cells were given fresh media containing 20 mM
IPTG, 1 ,uM DEX, and 5 ,uM CdCl2, alone and in combina-
tion. Each plasmid preparation used for transfection was
purified through CsCl-ethidium bromide equilibrium gradi-
ents. After transfection, the CAT extractions and assays
were performed as described below. For stable transfection,
XC36-2 cells (expressing the mutant lac repressor) were
plated on the day before transfection at a density of ca. 2 x
106 cells per 100-mm-diameter dish. Plasmid DNA was
introduced into these cells by the lipofection technique as
described previously (10). Specifically, 100 ,ul of DNA
solution (10 mM Tris hydrochloride, pH 8.0) containing 10
,g of either the hMTCAT or hMTlacO(-55)CAT construct
and 0.1 ,g of pY3 (3), which contains the hygromycin B
(hmB) phosphotransferase gene, was mixed gently with 100
,ul of the Lipofectin reagent (Bethesda Research Laborato-
ries), which contains the cationic lipid N-[1-(2,3-dioleylosy)
propyl]-N,N,N-trimethylammonium chloride and dioleoyl
phosphatidylethanolamine, in a polystyrene tube. Cells were
washed twice with 10 ml of DME without serum and
incubated in 5 ml of DME without serum. Then Lipofectin
reagent-DNA complex was added dropwise to the cells with
gentle swirling. After 20 h of incubation in a 5% CO2 37°C
incubator, S ml ofDME containing 20% FCS was added and
the cells were incubated for 48 h in the same incubator.
Three days after transfection, the media were replaced with
fresh DME containing 10% FCS, G418 (200 ,ug/ml), and hmB
(400 ,ug/ml). Four individual G-418- and hmB-resistant colo-
nies were trypsinized in cloning cylinders and transferred to
plastic microtiter wells. The remaining G418- and hmB-
resistant colonies (ca. 80 to 100) were trypsinized, pooled,
and transferred to plastic microtiter wells. Single and pooled
clonal lines were expanded and maintained in DME supple-
mented with 10% FCS, G418 (200 ,ug/ml), and hmB (200
,ug/ml). For induction experiments, cells were plated on the
day before induction at a density of 106 cells per 60-mm-
diameter plastic plate. The media were replaced with fresh
media containing 20 mM IPTG, 1 ,uM DEX, and/or 5 ,uM
CdCl2 as needed, and cells were incubated for 48 h before
harvesting.
CAT assays. CAT assays were performed as described
previously (14), with some modifications. After removal of
the media from 60-mm-diameter plates, the cells were
washed twice with 5 ml of phosphate-buffered saline at room
temperature. The cells were lysed directly on plates with 0.5
ml of CAT lysis buffer (0.25 M Tris hydrochloride [pH 7.8],
0.5% Nonidet P-40) for 5 min on ice. The solubilized and
insoluble cellular materials were removed with a cell scraper
and pipetted into a 1.5-ml microcentrifuge tube. These
samples were frozen in an ethanol-dry ice bath immediately
for 5 min and thawed in a 37°C water bath for 5 min.
Presumably, this freeze-thaw step can prevent protein ag-
gregation which may interfere with the enzymatic assay.
Soluble extracts were prepared by centrifugation in a micro-
centrifuge at 4°C for 10 min to pellet the insoluble material.
The protein content of each extract was determined by the
method of Bradford (5), using a standard curve prepared
with bovine immunoglobulin G (Bio-Rad). Aliquots of ex-
tracts containing equal amounts of protein, either 100 ,ug for
transient expressions or 400 ,ug for stable expressions, were
brought to a final volume of 100 p.1 by addition of 0.25 M Tris
hydrochloride (pH 7.8) prior to assay. Extracts were incu-
bated with [14C]chloramphenicol (50 mCi/mmol; Amersham)
and acetyl coenzyme A (Sigma) for 2 h at 37°C. Following
thin-layer chromatography, CAT activity was quantitated by
slicing the thin-layer chromatography plates and determining
the radioactivity (counts per minute) contained in the spots
corresponding to the acetylated [14C]chloramphenicol and
[J4C]chloramphenicol by liquid scintillation counting. The
values of specific CAT enzyme activities, expressed as
picomoles of ['4C]chloramphenicol converted per milligram
of protein per hour, are averages of four independent exper-
iments from transient expression except for pUCCAT (two
independent experiments) and of two independent experi-
ments from stable expression.
Analysis of integrated CAT-containing plasmid DNA. Nu-
clear DNA was prepared as described elsewhere (Hu and
Davidson, in press) and subjected to Southern blot analysis
after digestion with the restriction endonucleases BamHI
and HindIII, followed by blotting with the labeled 2.1-kb
BamHI-HindIII DNA probe containing the entire CAT-
coding sequence as gel isolated from hMTCAT.
Deposition of plasmids. Plasmid constructs hMTCAT,
hMTlacO(-10)CAT, hMT1acO(-35)CAT, hMTlacO(-55)
CAT, hMTlacO(-226)CAT, hMTlacO(-55)-S-CAT, and
hMTlacO(-226)-S-CAT described herein will be deposited
with the American Type Culture Collection, Rockville, Md.
RESULTS
Description of chimeric hMT-IIA promoters carrying the
lacO sequence. As described in Materials and Methods, the
human hMT-IIA promoter was mutated to permit convenient
insertion of a 30-bp symmetric lacO sequence between the
TATA box and the transcription start point [hMTlacO(-10)
CAT], between the TATA box and MRE 1 [hMTlacO(-35)
CAT], between MRE 1 and the GC box [hMTlacO(-55)
CAT], and further upstream between BLE2 and the GRE
[hMT1acO(-226)CAT]. The sequence of the promoter and
the positions of the several inserts are shown in Fig. 1.
In addition, a lacO insert spaced on each side by 190 bp of
pBR322 DNA (hopefully innocuous DNA) was inserted at
positions -55 and -226 [designated hMT1acO(-55)-S-CAT
and hMTIacO(-226)-S-CAT]. The purpose of these latter
two constructs was to test the effect of binding of a lac
repressor to the operator when direct protein-protein con-
tacts of bound repressor with adjacent regulatory proteins
was not possible without looping or bending.
Effect of the lacO inserts on expression in the absence of
repressor. Before study of repression by the lac repressor
and derepression by IPTG, it was necessary to examine the
effects of the lacO inserts at the several sites on expression
in the absence of repressor. These experiments were carried
out in XC and Rat 2 cell lines, both of which express
reasonable levels of glucocorticoid receptor and thus permit
glucocorticoid induction of the hMT promoter. The results
were not cell line dependent, and only results for XC are
presented in detail.
As described in Materials and Methods, the transfection
protocols were carried out four times independently, with
carefully monitored amounts of DNA and numbers of cells,
and protein assays of cell lysates were performed to ensure
that equal amounts of extract were used for all CAT assays.
All measurements were within the linear activity range for
the assay. These procedures were adopted to achieve satis-
factory reproducibility and linearity of the data.
The CAT assays for transfected XC cells are shown in Fig.
2 and summarized in Table 1. Even in the absence of
repressor protein, insertion of the 30-bp lacO sequence at
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FIG. 2. Repression and induction of CAT activity after transient transfection with various constructs in XC cells (repressor negative).
Transient transfection experiments were carried out with the CAT-containing plasmid constructs listed in Table 1. Plates (60-mm diameter)
of ca. 106 XC cells were transfected with 4 ,ug (at a 2-4Lg/ml final concentration) of plasmid DNA, as indicated in each panel, by using the
DEAE-dextran protocol. After transfection, cells were cultured where indicated in medium with (+) or without (-) extracellular inducers
(DEX, Cd2" ion, and/or IPTG) for 48 h before being harvested for determination of CAT activity. Aliquots of extracts containing 100 p.g of
protein were adjusted to a final volume of 100 ,ul and assayed in parallel for CAT activity. CAT assays were performed as described in the
footnote to Table 1 and Materials and Methods.
sites -10, -35, and -55 reduced the uninduced (basal) level For hMTCAT, we observed 9 + 3- and a 5 2-fold
of expression by a factor of about 10 compared with the level induction by DEX and Cd2+ ions, respectively, over the
of parental promoter in hMTCAT. At the well-upstream basal levels whereas the combined effect of DEX plus Cd2+
position, -226, the uninduced level of expression was about produced a 13 + 6-fold induction. Thus, the combined
one-half that of hMTCAT. Uninduced levels ofCAT expres- effects of the two inducers were greater than the effect of
sion for the larger inserts of the -S-CAT series at -55 or either alone but much less than the product of the two
-226 were not significantly lower than those of the parental induction ratios.
promoter. The effects of the short lacO insertions on induced levels
TABLE 1. Effects of inducers on transient expression of CAT activity after transfection of XC cells with various constructs'
CAT activity
Construct - - + + - - + +
_-
+ + + +
_ + _+ -+ - +
hMTCAT 33 + 10 39 ± 10 (1.2) 281 ± 86 (9) 381 ± 98 (12) 148 ± 52 (5) 223 ± 63 (7) 441 ± 200 (13) 506 ± 206 (15)
hMTlacO(-10)CAT 5 + 2 7 ± 2 (1.4) 76 ± 52 (15) 102 ± 37 (20) 44 ± 26 (9) 72 ± 45 (14) 188 ± 126 (38) 217 ± 122 (43)
hMTlacO(-35)CAT 3 + 1 3.5 ± 1 (1.2) 19 + 12 (6) 31 + 15 (10) 15 + 9 (5) 27 ± 13 (9) 65 ± 46 (22) 94 ± 50 (31)
hMTIacO(-55)CAT 4 + 1 6 ± 2 (1.5) 59 + 31 (15) 83 + 46 (21) 32 + 19 (8) 46 ± 22 (12) 170 ± 113 (43) 202 ± 122 (51)
hMTlacO(-226)CAT 16 ± 6 21 ± 7 (1.3) 59 + 19 (4) 89 + 23 (6) 78 + 19 (5) 106 ± 21 (7) 160 ± 77 (10) 212 ± 64 (13)
hMTIacO(-55)-S-CAT 26 ± 7 31 ± 10 (1.2) 128 + 19 (5) 168 + 54 (6) 71 + 13 (3) 77 ± 25 (3) 221 ± 25 (9) 212 ± 26 (8)
hMTIacO(-226)-S-CAT 30 ± 11 38 ± 12 (1.3) 94 + 16 (3) 113 + 23 (4) 140 ± 44 (5) 153 ± 48 (5) 217 ± 62 (7) 258 ± 65 (9)
pUCCAT 2 ± 0.5 2 ± 1 (1) 2 1 (1) 2.5 + 1 (1.3) 1.6 ± 0.5 (1) 2.2 ± 1 (1.1) 2.3 ± 1 (1.2) 2.5 ± 1 (1.3)
aPlates (60-mm diameter) of XC cells were transfected with the indicated CAT-containing plasmid constructs. Twelve hours after transfection, the cells were
incubated as indicated in medium with (+) or without (-) various inducers (DEX [top row of symbols], Cd2+ [middle row], and/or IPTG [bottom row]) for 48
h before being harvested and assayed for CAT activity as described in Materials and Methods. Activities in inducer-treated cells were divided by those in
untreated cells to yield the fold induction, which is indicated in parentheses.
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TABLE 2. Effects of inducers on transient expression of CAT activity after transfection of XC35-5 cells with various constructsa
CAT activity
Construct - - + + - - + +
_-
+ + + +
_ + _+ -+
-+
hMTCAT 76 ± 10 88 ± 23 (1.2) 375 ± 120 (5) 534 ± 185 (7) 237 ± 89 (3) 336 ± 131 (4) 475 ± 195 (6) 694 ± 263 (9)
hMTlacO(-10)CAT 1.7 ± 0.4 15 + 5 (9) 16 ± 8 (9) 131 ± 62 (77) 12 ± 5 (7) 86 ± 33 (51) 38 ± 17 (22) 196 ± 91 (115)
hMTlacO(-35)CAT 1.5 ± 0.5 6 ± 2 (4) 10 ± 4 (7) 43 ± 18 (29) 8 ± 4 (5) 30 ± 16 (20) 28 ± 12 (19) 119 ± 56 (79)
hMTlacO(-55)CAT 3 ± 1 17 ± 6 (6) 40 ± 14 (13) 154 ± 57 (51) 31 ± 14 (10) 94 ± 30 (31) 100 + 47 (33) 295 ± 118 (98)
hMTlacO(-226)CAT 44 ± 11 56 ± 15 (1.3) 134 ± 31 (3) 172 ± 52 (4) 156 ± 57 (4) 218 ± 90 (5) 250 + 107 (6) 325 ± 136 (7)
hMTIacO(-55)-S-CAT 71 ± 22 180 ± 51 (3) 151 ± 57 (2) 371 ± 147 (5) 89 ± 11 (1.3) 243 ± 96 (3) 150 ± 52 (2) 415 ± 180 (6)
hMT1acO(-226)-S-CAT 114 ± 34 115 ± 36 (1) 294 + 98 (3) 299 ± 109 (3) 328 ± 156 (3) 285 ± 133 (3) 465 ± 233 (4) 466 + 191 (4)
pUCCAT 5 1 6± 2 (1.2) 4 1 (1) 6 3 (1.2) 5 ± 2 (1) 7 3 (1.4) 5± 2 (1) 6 2 (1.2)
a CAT assays were performed with extracts derived from XC35-5 cells transfected with the various CAT-containing plasmid constructs as described in the
footnote to Table 1. Specific CAT activity and fold induction are expressed in Table 1.
of expression depended to some extent on the site of
insertion. The induced levels of expression generally were
somewhat higher for the -10 insertion than for the others.
The -226 insertion showed a weaker response to DEX than
did the other promoters, consistent with the position of the
-226 insertion relatively close to the GRE. Whereas the
lacO (-226)-S-CAT insert did not have a significant effect on
expression in the presence of Cd2+ or IPTG, it had a two- to
threefold negative effect on DEX-induced expression.
Contrary to expectation, addition of IPTG to the repres-
sor-minus XC cells seemed to cause a slight increase in CAT
expression level. The effects were all within the rather large
experimental variability but consistently in one direction,
suggesting the existence of a small nonspecific effect.
Induction and IPTG derepression of CAT expression in
repressor-plus cells. Tables 2 and 3 summarize the CAT
activity results for XC35-5 cells (expressing the wild-type
repressor) and XC36-2 cells (expressing the modified repres-
sor with a karyophilic sequence). Generally, there was very
little difference between the results for the wild-type and
modified (NLS-containing) repressor, and we will focus on
the former (Fig. 3 and Table 2).
Figure 3 is a bar graph with a visual presentation of the
data in Table 2. The data are grouped in sets of four to
compare the effect of IPTG treatment on a construct con-
taining a lacO insert with the effect for the hMTCAT
construct that does not contain a lacO insert in the presence
or absence of DEX and Cd2+. To simplify visual presenta-
tion, the expression levels of hMTCAT are divided by 6.
In the absence of IPTG in these repressor-positive cells,
the CAT expression levels with the lacO inserts at -10, -35,
and -55 were much less than one-sixth the level for hMT
CAT. This was the case regardless of the presence or
absence of DEX and Cd2". When IPTG was added, dere-
pression occurred and the expression levels for lacO(-10),
-(-35), and -(-55) were increased to a value between one-
third and one-sixth that of hMTCAT; i.e., there was a very
significant derepression (by a factor of 5 to 10) upon the
addition of IPTG under any particular condition of induction
by DEX and Cd2 . Most strikingly, high overall induction
ratios of 100 to 115 over the basal level of expression were
observed for the combination of DEX, Cd2+, and IPTG for
either the XC35-5 cells or the XC36-2 cells for the -10, -35,
and -55 constructs. However, the total CAT activity was
still three- to fourfold higher in hMTCAT than in any of the
fully induced lacO inserts, although the induction ratios
were much less marked for hMTCAT.
The effects of adding IPTG on expression by the lacO
(-226) construct were quite small (Fig. 3). As noted earlier,
the insert reduced expression levels by a factor of slightly
less than 2 for the uninduced and plus-Cd2+ conditions and
by about 3 for any plus-DEX conditions, but these ratios
were unchanged when IPTG was added. Expression levels
for the long inserts, (-55)-S-CAT and (-226)-S-CAT, were
similar to those for hMTCAT and not significantly influenced
by IPTG (Tables 1 to 3).
Stable transfectants give similar results. Stable transfec-
tants of the hMTlacO(-55)CAT and hMTCAT constructs
were prepared by cotransformation of XC36-2 cells with an
hmB gene as the selectable marker as described in Materials
and Methods. Stable transfectants were selected in media
supplemented with hmB. After 8 days in selective medium,
TABLE 3. Effects of inducers on transient expression of CAT activity after transfection of XC36-2 cells with various constructsa
CAT activity
Construct - - + + - - + +
_-
+ + + +
_ + _+ -+
-+
hMTCAT 67 ± 12 84 ± 20 (1.3) 383 ± 84 (6) 560 + 127 (8) 183 ± 60 (3) 284 ± 100 (4) 461 ± 116 (7) 639 ± 145 (10)
hMTlacO(-10)CAT 1.5 ± 0.5 14 ± 3 (9) 11 ± 4 (7) 94 ± 18 (63) 7 ± 3 (5) 66 ± 14 (44) 24 ± 9 (16) 170 ± 22 (113)
hMTlacO(-35)CAT 1.5 ± 0.5 6 ± 2 (4) 7 ± 2 (5) 32 ± 6 (21) 6 ± 2 (4) 24 ± 3 (16) 24 ± 8 (16) 100 ± 21 (67)
hMTlacO(-55)CAT 2.2 ± 0.4 13 ± 2 (6) 25 ± 6 (11) 131 ± 32 (60) 21 ± 6 (10) 68 ± 16 (31) 70 ± 16 (32) 243 ± 21 (110)
hMTlacO(-226)CAT 44 ± 17 47 ± 10 (1) 114 ± 33 (3) 147 ± 29 (3) 177 ± 38 (4) 201 ± 42 (5) 230 ± 55 (5) 314 ± 45 (7)
hMT1acO(-55)-S-CAT 54 ± 13 125 ± 18 (2.3) 148 ± 55 (3) 337 ± 106 (6) 69 ± 15 (1.3) 193 ± 43 (4) 136 ± 37 (3) 412 ± 103 (8)
hMTIacO(-226)-S-CAT 78 ± 13 72 ± 12 (1) 228 ± 41 (3) 216 ± 35 (3) 217 ± 48 (3) 199 ± 34 (3) 344 ± 100 (4) 362 ± 87 (5)
pUCCAT 4 ± 1 4.5 ± 1 (1) 4± 1 (1) 4 ± 1 (1) 3.5 0.5 (1) 4.5 0.5 (1) 4 1 (1) 4 0.5 (1)
a CAT assays were performed with extracts derived from XC36-2 cells transfected with the various CAT-containing plasmid constructs as described in the
footnote to Table 1. Specific CAT activity and fold induction are expressed as in Table 1.
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FIG. 3. Relative CAT expression levels of constructs with and without a lacO insert in cells expressing the lac repressor. Symbols: _,
indicated lacO insertions; l , hMTCAT construct (no lacO insert). Values are plotted on a log1o scale. The values for hMTACAT have beendivided by 6. Data are from XC35-5 cells (see Table 2).
four hmB-resistant colonies were isolated as single clones
for each construct, and the remaining transformants (ca. 80
to 100 colonies) were pooled. These isolates were expanded
as needed and then tested for CAT expression levels under
various conditions. Southern blot analysis showed that the
copy number of the integrated CAT sequence was 10 to 20.
The effects of the lacO insert in XC cells and of several
inducers, including IPTG, were essentially the same as for
the transient expression experiments (Table 4).
DISCUSSION
For an inducible gene such as the hMTCAT gene, the
value'of the basal level of expression in the absence of any
added inducers will depend on the level of metal ion,
hormone, and other inducers in the cell culture medium
used. For -stable transfectants, it will also vary with the
integration site and structure of the integrated DNA. Thus,
the basal level of expression is likely to vary in the hands of
different experimenters. For this reason, the total induction
ratios reported (e.g., in Table 2) as the ratios of the CAT
enzyme level in the presence and absence of DEX, Cd2",
and IPTG for any given construction and cell type are likely
to be different when tested in different laboratories.
Nevertheless, the major result reported here is that induc-
tion ratios of about 100 were measured for the -10, - 35, and
-55 inserts. In a practical sense, the basic objective of this
study, namely, to combine positive induction ofgene expres-
sion due to the endogenous hormone and metal ion-respon-
sive sequences of the metallothionein gene with an addi-
tional level of control by using the lac repressor and
operator, has been met.
One striking and unexpected result of this work was the
marked (ca. 10-fold) reduction of expression due to the lacO
insert at -10, -35, -55 in the XC repressor-negative cells.
In our previous study, the effects of a single lacO insert into
a similar position in the promoter used were at most 5%o,
depending on the point of insertion (15). These results were
in a different cell type (Ltk-), with a 40-bp natural lacO
sequence instead of the symmetric 30-bp lacO insert used
here, and with a different promoter (a hybrid Moloney
sarcoma virus-SV40 promoter). Thus, precise comparisons
are impossible; nevertheless, the much greater' inhibitory
effect of the symmetric lacO insertion in the study described
here is striking. Possible mechanisms for this result are
discussed below.
We note parenthetically that even in XC cells, the
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TABLE 4. Effects of inducers on stable expression of CAT activity in cell clones of XC36-2 cells transfected with various constructsa
CAT activity
Constructs - - + + - - + +
_-
+ + + +
_ + _+ -+ -+
hMTCAT (pooled 264 ± 5 333 ± 14 (1.2) 1,344 ± 133 (5) 1,414 + 42 (5) 593 ± 15 (2) 858 ± 32 (3) 1,082 ± 81 (4) 1,202 ± 10 (5)
clones)
hMTIacO(-55)CAT 3 ± 0.5 32 ± 10 (11) 39 ± 8 (13) 168 ± 14 (48) 37 ± 2 (12) 140 ± 3 (40) 108 ± 4 (36) 335 ± 13 (96)
(pooled clones)
hMTCAT (single 235 ± 10 355 ± 21 (1.5) 1,378 ± 11 (6) 1,399 ± 9 (6) 474 ± 19 (2) 717 ± 36 (3) 1,182 ± 16 (5) 1,238 ± 34 (5)
clones)
hMTIacO(-55)CAT 5 ± 1 49 ± 4 (10) 67 ± 6 (13) 235 ± 13 (47) 48 ± 4 (10) 122 ± 8 (24) 171 ± 13 (34) 385 ± 31 (77)
(single clones)
a XC36-2 cells were transfected with CAT-containing plasmids and plasmid pY3, which carries the hmB phosphotransferase gene, and stable cotransfectants
were isolated as described in Materials and Methods. Specific CAT activity and fold induction are expressed as in Table 1.
hMTlacO(-10)CAT construct gave rather good induction
ratios of 38 for DEX plus Cd2" and 43 for DEX plus Cd2"
plus IPTG. If similar results obtain with other reporter genes
and the same promoter, this construction could be useful for
studies in which it is impractical to prepare a lac repressor-
positive cell line.
The results for induction ratios with cells expressing the
modified repressor containing the SV40 karyophilic se-
quence were about the same as those for the wild-type
repressor, probably because, as reported elsewhere (Hu and
Davidson, in press), the effective concentration of functional
repressor in the nucleus was about fourfeld less for the
mutant than for the wild-type repressor. The XC35-5 line
expressed ca. 8 x 105 monomer subunits per cell, all of
which were assembled into functional tetramers, but only 2
x 104 of these were localized in the nucleus (Hu and
Davidson, in press). The XC36-2 cells expressed 1.6 x i05
monomers per cell, all of which were in the nucleus. How-
ever, the effective concentration of functional tetramers, as
assayed by lacO binding in vitro in the presence of an excess
of nonspecific DNA, was only 5 x i03 per nucleus. The
reason for this finding is either inefficient assembly of
monomer peptide subunits into tetramers or a reduced
affinity of the modified, more positively charged repressor
for the operator relative to nonspecific DNA binding (Hu and
Davidson, in press). However, the somewhat disappointing
result with this particular modified repressor does not nec-
essarily mean that other constructs, with this or some other
karyophilic sequence inserted at different points in the lac
repressor, will not be more effective. A determination of the
full three-dimensional structure of the repressor will be
useful for this purpose (31). Furthermore, NLSs with only
three or four basic amino acids are known (8) and might be
more effective than the T-antigen signal for fusing to a
functional lac repressor.
While this report was under review, a description of an
interesting related but alternative approach based on the lac
operator-repressor interaction appeared (22). Labow et al.
(22) added the SV40 T-antigen NLS to the amino termini of
several lacI gene constructs. They observed that this signal
directed the lacI-containing gene product to the nucleus, just
as did the carboxy-terminal NLS studied by us (Hu and
Davidson, in press). Most importantly, these authors made a
fusion protein of the lac repressor with the carboxy-terminal
(100-amino-acid) transactivating domain of the herpes sim-
plex virus virion protein 16. Cotransfection of this construct
with a CAT vector containing an enhancerless SV40 pro-
moter into which one or multiple lac operator elements had
been inserted resulted in very high levels of expression due
to transactivation.
The method described here was designed to provide a high
level of induction of a particular transfected gene in a cell by
simultaneous induction with Cd2" and/or glucocorticoid and
derepression by IPTG. This is important when the trans-
fected gene product is toxic to the cell or generally when one
wishes to see the effect of change in gene expression in an
otherwise constant cell bak-kround. In the system described
by Labow et al. (22), the only level of control is by
IPTG-induced dissociation of the transactivator from the
lacO segment. The induction ratios reported by Labow et al.
do not appear to be quite as high as those reported by us;
however, the maximum level of expression achieved appears
to be much higher. In the method of Labow et al., it is
necessary to maintain the cells in the presence of IPTG to
keep the gene in an off state, whereas in our method, IPTG
is added to cause derepression.
Effects of the lacO insertion at different positions and
implications as to the mechanism of regulatory controls. It is
of interest to consider the dependence of the results on the
site of insertion of the lacO segment both from the practical
viewpoint of engineering effective control systems and be-
cause of the insights that these results may provide as to the
mechanisms of regulatory protein interactions at a promoter.
In general, sequence-specific transcription factors activate
or repress transcription of a gene by binding to cis sequence
elements in the neighborhood of the gene. Many of these
elements are within several hundred base pairs of the gene,
but some (enhancers) can act over greater distances and in
an orientation-independent manner. The bound transcription
factors interact with each other and with RNA polymerase in
ways that are not well understood to control the rate of
initiation of transcription (for reviews, see references 27, 30,
32, 33, and 36).
Proteins bound to neighboring cis sequence segments
presumably interact by direct protein-protein contact. The
occurrence of flexibility and partial bending of the DNA
chain to allow protein-protein contact is suggested by the
observation that separating nearby elements by spacers of
length 5 or 15 bp decreases transcription more than does
insertion of spacer DNA of 10 or 21 bp (39).
There are two general classes of proposed mechanisms for
the action of transcription factors that bind at more distant
enhancer elements. One is action through space by looping
of DNA or chromatin, thus permitting protein-protein con-
tact (32, 36). The alternative mechanism is action through
the chain, possibly because the enhancer serves as an RNA
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polymerase entry site, from which the polymerase slides
along the DNA to the transcription start point (28) or
possibly because the enhancer-binding protein initiates DNA
unwinding, which then somehow propagates down the
chain. New experimental evidence (29) as well as the con-
sensus of current opinion favor the looping model.
In this study, the lacO was inserted into several sites in the
promoter region of the hMT-IIA gene. The positions of the
known cis-acting elements, as summarized in reference 19,
are shown in Fig. 1.
(i) The 30± 4-bp lacO insertion has a marked negative effect
on transcription. Because of the nature of the DNA manip-
ulations, the insertion at the Scal site (-10) is exactly 30 bp
in length; at the XhoI site (-35) it is 34 bp, and at the SphI
sites (either -55 or -226) it is 26 bp. The depression by
10-fold of constitutive transcription levels for the insertions
at -10, -35, and -55 (Table 1) is much greater than the 50%
effect that we observed in our earlier work (15) for insertions
of the native lacO 40-bp sequence into a Moloney sarcoma
virus-SV40-based promoter. It would be necessary to test
some other 30 + 4-bp spacer DNA insertions to determine
whether the specific symmetric lacO sequence has an un-
usual inhibiting effect on gene expression even in the ab-
sence of repressor. The observation that the insertion at
-226, a position that seems to be well separated from all
known control sequences, has a twofold inhibiting effect
encourages the speculation that there is a specific effect,
perhaps due to adventitious eucaryotic protein binding, of
the 30-bp lacO sequence.(ii) Insertions at -226. In repressor-positive cells (Tables 2
and 3), the insertion of lacO plus spacer DNA at -226, just
downstream of the GRE, had only a ca. 33% negative effect
on glucocorticoid-induced expression; the 30-bp insertion
without spacer at this position reduced DEX-induced
expression by ca. 66%. If one assumes that repressor binding
would block action through the chain, these results favor the
looping model for action at a distance.
(iii) Insertions at -55. The lacO insertion at -55 lies very
close to (and just downstream of) the Spl-binding site (GC
box in Fig. 1) and close to (and just upstream of) MRE1 but
more distant from MRE2, -3, or -4. lac repressor bound at
this site had a three- to fivefold negative effect on expression
in the presence of DEX (as judged by the effect of adding
IPTG) and a three- to fourfold negative effect in the presence
of Cd2+ (Tables 2 and 3). The effect in the presence of DEX
suggests that one of the factors with which the glucocorti-
coid receptor bound at the GRE must interact in order to
stimulate transcription is Spl bound at the GC box. We then
assume that bound lac repressor at -55 prevents or modifies
the binding of Spl to the GC box. Evidence for a synergistic
interaction of the bound glucocorticoid receptor with Spl
and other factors has been presented elsewhere (35, 37).
Similarly, the fact that lac repressor bound at the -55 site
has a three- to fivefold negative effect on Cd2'-induced
expression suggests that the MRE-bound factors also inter-
act with Spl. lac repressor bound to the lacO insert with
spacer DNA at -55 had essentially no effect on expression
in the presence of DEX or Cd2 . It would thus appear that
looping mechanisms are effective in permitting interactions
of all of the needed factors despite the presence of lac
repressor in the center of the long insertion. This model is
depicted in Fig. 4.
(iv) Insertions at -35 and -10. The insertions at -35 and
-10 lie between MRE1 and the TATA site (Fig. 1) and
between the latter and the transcription start point, respec-
tively. In repressor-positive cells, the greatest effects on
+1
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FIG. 4. Schematic model for transcriptional activation and re-
pression by proximal promoter factors in the absence or presence of
lac repressor. The GC box-binding factor Spl (GC), the TATA box-
binding factor complex (TATA), and the lac repressor tetramers (R)
are indicated. A solid arrow indicates active transcription from the
transcription start site (+ 1); a dashed arrow indicates that transcrip-
tion is not active.
expression in the absence of IPTG were observed for these
two insertions (Tables 2 and 3). Effects due to the -35
insertion appeared to be somewhat greater than for the -10
insertion. For the latter case, overall induction ratios of ca.
100 were achieved in the presence of IPTG plus DEX plus
c2+.Cd2~
We suggest that repressor at -35 interferes with binding of
protein to the TATA box, with the interaction of upstream
proteins with the TATA box binding protein, or with both.
Repressor binding at the -10 insert may interfere directly
with the TATA box site, but it is closer to the transcription
start point and may interfere primarily with binding of an
RNA polymerase complex at the transcription start point (7).
Overall, our results are consistent with the view that two
transcription factors bound at their respective specific sites
can interact by direct contact if the specific cis sequences are
adjacent, by gentle bending if the cis sequences are sepa-
rated by short (10- to 50-bp, perhaps) spacer DNA, or by
looping for larger spacings. Repressor bound to a short lacO
insertion can interfere with interactions involving a tran-
scription factor that is bound very close to the lacO se-
quence. However, when the lacO sequence is flanked by
long spacer DNA (190 bp in our case), interactions by
looping are not inhibited by bound repressor. This general
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view should serve as a guide in designing other constructions
for the control of gene expression.
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